Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Deferred Tax Assets (2020)

Historic Current Deferred Tax Assets for Terns Pharmaceuticals (TERN) over the last 1 years, with Q4 2020 value amounting to $2.1 million.

  • Terns Pharmaceuticals' Current Deferred Tax Assets changed N/A to $2.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Current Deferred Tax Assets of $2.1 million as of Q4 2020.
  • Over the past 5 years, Terns Pharmaceuticals' Current Deferred Tax Assets peaked at $2.1 million during Q4 2020, and registered a low of $2.1 million during Q4 2020.